Uncategorized

AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes

Published

on

AbCellera Biologics’ reduction in hot flashes sets it apart from currently commercial oral drugs, including Astellas’ Veozah and Bayer’s Lynkuet, according to BMO Capital Markets.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version